# Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

> **NCT01644994** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 47 (actual)

## Conditions studied

- Malignant Pleural Mesothelioma

## Interventions

- **COMBINATION_PRODUCT:** intracavitary cisplatin-fibrin

## Key facts

- **NCT ID:** NCT01644994
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2019-12
- **Final completion:** 2021-08
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2021-09-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01644994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01644994, "Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01644994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*